Tortoise Investment Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-3,661
Closed -$93.3K 1099
2025
Q3
$93.3K Buy
3,661
+99
+3% +$2.44K 0.01% 320
2025
Q2
$86.3K Sell
3,562
-333
-9% -$7.77K 0.01% 313
2025
Q1
$98.7K Sell
3,895
-215
-5% -$5.63K 0.01% 289
2024
Q4
$109K Sell
4,110
-115
-3% -$3.12K 0.01% 294
2024
Q3
$122K Buy
4,225
+145
+4% +$4.23K 0.01% 285
2024
Q2
$114K Buy
4,080
+629
+18% +$17.3K 0.01% 280
2024
Q1
$95.8K Buy
3,451
+7
+0.2% +$194 0.01% 299
2023
Q4
$99.1K Sell
3,444
-2,382
-41% -$72K 0.01% 275
2023
Q3
$193K Sell
5,826
-474
-8% -$16.8K 0.03% 197
2023
Q2
$231K Buy
6,300
+350
+6% +$13.6K 0.03% 181
2023
Q1
$243K Hold
5,950
0.04% 175
2022
Q4
$305K Buy
5,950
+170
+3% +$8.15K 0.05% 162
2022
Q3
$253K Buy
5,780
+1,455
+34% +$70.7K 0.05% 163
2022
Q2
$227K Buy
4,325
+400
+10% +$20.4K 0.04% 166
2022
Q1
$203K Buy
3,925
+80
+2% +$4.15K 0.04% 178
2021
Q4
$227K Buy
3,845
+50
+1% +$2.48K 0.04% 157
2021
Q3
$163K Sell
3,795
-1,275
-25% -$56.5K 0.03% 172
2021
Q2
$199K Hold
5,070
0.04% 158
2021
Q1
$184K Buy
5,070
+104
+2% +$3.69K 0.04% 155
2020
Q4
$183K Sell
4,966
-163
-3% -$5.98K 0.04% 149
2020
Q3
$179K Hold
5,129
0.04% 146
2020
Q2
$159K Sell
5,129
-161
-3% -$5.47K 0.04% 150
2020
Q1
$164K Sell
5,290
-1,281
-19% -$43.6K 0.05% 143
2019
Q4
$244K Buy
6,571
+743
+13% +$26.5K 0.06% 126
2019
Q3
$199K Sell
5,828
-2,334
-29% -$84.9K 0.05% 139
2019
Q2
$335K Buy
8,162
+472
+6% +$18.7K 0.08% 117
2019
Q1
$310K Sell
7,690
-629
-8% -$25.2K 0.08% 113
2018
Q4
$345K Sell
8,319
-1,160
-12% -$48.2K 0.09% 110
2018
Q3
$396K Hold
9,479
0.1% 105
2018
Q2
$326K Buy
9,479
+633
+7% +$21.6K 0.09% 118
2018
Q1
$298K Buy
8,846
+451
+5% +$15.5K 0.08% 120
2017
Q4
$288K Sell
8,395
-40
-0.5% -$1.36K 0.08% 119
2017
Q3
$286K Buy
8,435
+2,635
+45% +$84.7K 0.09% 114
2017
Q2
$185K Sell
5,800
-351
-6% -$11.1K 0.06% 124
2017
Q1
$200K Buy
6,151
+74
+1% +$2.33K 0.07% 112
2016
Q4
$187K Buy
6,077
+3,826
+170% +$117K 0.06% 111
2016
Q3
$72K Hold
2,251
0.02% 164
2016
Q2
$75K Hold
2,251
0.03% 164
2016
Q1
$63K Sell
2,251
-1,313
-37% -$37.5K 0.02% 178
2015
Q4
$109K Sell
3,564
-263
-7% -$8.27K 0.04% 139
2015
Q3
$114K Sell
3,827
-300
-7% -$9.62K 0.04% 133
2015
Q2
$131K Buy
4,127
+317
+8% +$10.3K 0.05% 137
2015
Q1
$126K Buy
3,810
+587
+18% +$18.7K 0.05% 137
2014
Q4
$95K Buy
3,223
+306
+10% +$8.77K 0.04% 162
2014
Q3
$82K Sell
2,917
-1,677
-37% -$47.1K 0.03% 169
2014
Q2
$129K Buy
4,594
+2,706
+143% +$77.1K 0.05% 127
2014
Q1
$58K Buy
+1,888
New +$56.3K 0.03% 182
2013
Q4
Sell
-791
Closed -$22K 374
2013
Q3
$22K Buy
791
+214
+37% +$5.82K 0.01% 196
2013
Q2
$15K Buy
+577
New +$15.9K 0.01% 204

Other funds holding PFE

Tortoise Investment Management's PFE Position: Q4 2025 in Review

Tortoise Investment Management sold out of Pfizer (PFE) in Q4 2025, closing a stake of 3,661 shares — an estimated $93.3K sold.

Tortoise Investment Management first reported a position in PFE in Q2 2013 and held it in 49 quarters. The position peaked at $396K in Q3 2018. 2,914 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

  • Tortoise Investment Management reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
  • Tortoise Investment Management sold 3,661 Pfizer shares in Q4 2025, an estimated $93.3K.
  • Tortoise Investment Management first reported a position in Pfizer in Q2 2013 and held it in 49 quarters.
  • Tortoise Investment Management's Pfizer position peaked at $396K in Q3 2018.
  • 2,914 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on Tortoise Investment Management's 13F filing for Q4 2025, filed 6 Feb 2026.